Skip to main content
Top
Published in: European Journal of Medical Research 1/2023

Open Access 01-12-2023 | Ultrasound | Research

Diagnostic efficiency on ultrasound shear wave elastography in evaluation of steatosis severity for non-alcoholic fatty liver disease: a rat model

Authors: Yuhui Wu, Qianjiao Liu, Yan Wang, Fangyan Li, Lawrence Wing-Chi Chan, Yong Wen, Fan Yang, Yining Xiang, Qinghong Duan, Peng Luo, Pinggui Lei

Published in: European Journal of Medical Research | Issue 1/2023

Login to get access

Abstract

Background

The pathological feature of steatosis affects the elasticity values measured by shear wave elastography (SWE) is still controversial in non-alcoholic fatty liver disease (NAFLD). The aim of this study is to demonstrate the influence of steatosis on liver stiffness measured by SWE on a rat model with NAFLD and analyze feasibility of SWE for grading steatosis in absence of fibrosis.

Methods

Sixty-six rats were fed with methionine choline deficient diet or standard diet to produce various stages of steatosis; 48 rats were available for final analysis. Rats underwent abdominal ultrasound SWE examination and pathological assessment. Liver histopathology was analyzed to assess the degree of steatosis, inflammation, ballooning, and fibrosis according to the non-alcoholic fatty liver disease activity score. The diagnostic performance of SWE for differentiating steatosis stages was estimated according to the receiver operating characteristic (ROC) curve. Decision curve analysis (DCA) was conducted to determine clinical usefulness and the areas under DCA (AUDCAs) calculated.

Results

In multivariate analysis, steatosis was an independent factor affecting the mean elastic modules (B = 1.558, P < 0.001), but not inflammation (B =  − 0.031, P = 0.920) and ballooning (B = 0.216, P = 0.458). After adjusting for inflammation and ballooning, the AUROC of the mean elasticity for identifying S ≥ S1 was 0.956 (95%CI: 0.872–0.998) and the AUDCA, 0.621. The AUROC for distinguishing S ≥ S2 and S = S3 was 0.987 (95%CI: 0.951–1.000) and 0.920 (95%CI: 0.816–0.986) and the AUDCA was 0.506 and 0.256, respectively.

Conclusions

Steatosis is associated with liver stiffness and SWE may have the feasibility to be introduced as an assistive technology in grading steatosis for patients with NAFLD in absence of fibrosis.
Literature
1.
go back to reference Fouad Y, Waked I, Bollipo S, Gomaa A, Ajlouni Y, Attia D. What’s in a name? Renaming “NAFLD” to “MAFLD.” Liver Int. 2020;40(6):1254–61.CrossRefPubMed Fouad Y, Waked I, Bollipo S, Gomaa A, Ajlouni Y, Attia D. What’s in a name? Renaming “NAFLD” to “MAFLD.” Liver Int. 2020;40(6):1254–61.CrossRefPubMed
2.
go back to reference Fujii H, Kawada N, Japan SGON. The role of insulin resistance and diabetes in nonalcoholic fatty liver disease. Int J Mol. 2020;21(11):3863.CrossRef Fujii H, Kawada N, Japan SGON. The role of insulin resistance and diabetes in nonalcoholic fatty liver disease. Int J Mol. 2020;21(11):3863.CrossRef
3.
go back to reference Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–2014.CrossRefPubMed Eslam M, Sanyal AJ, George J. MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease. Gastroenterology. 2020;158(7):1999–2014.CrossRefPubMed
5.
go back to reference Pagadala MR, McCullough AJ. The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis. Clin Liver Dis. 2012;16(3):487–504.CrossRefPubMedPubMedCentral Pagadala MR, McCullough AJ. The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis. Clin Liver Dis. 2012;16(3):487–504.CrossRefPubMedPubMedCentral
6.
go back to reference Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(5):1264–81.CrossRefPubMed Castera L, Friedrich-Rust M, Loomba R. Noninvasive assessment of liver disease in patients with nonalcoholic fatty liver disease. Gastroenterology. 2019;156(5):1264–81.CrossRefPubMed
7.
go back to reference Lupsor-Platon M, Stefanescu H, Muresan D, Florea M, Szasz ME, Maniu A, et al. Noninvasive assessment of liver steatosis using ultrasound methods. Med Ultrason. 2014;16(3):236–45.PubMed Lupsor-Platon M, Stefanescu H, Muresan D, Florea M, Szasz ME, Maniu A, et al. Noninvasive assessment of liver steatosis using ultrasound methods. Med Ultrason. 2014;16(3):236–45.PubMed
8.
go back to reference Borges VF, Diniz AL, Cotrim HP, Rocha HL, Andrade NB. Sonographic hepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis. J Clin Ultrasound. 2013;41(1):18–25.CrossRefPubMed Borges VF, Diniz AL, Cotrim HP, Rocha HL, Andrade NB. Sonographic hepatorenal ratio: a noninvasive method to diagnose nonalcoholic steatosis. J Clin Ultrasound. 2013;41(1):18–25.CrossRefPubMed
9.
go back to reference van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, Ten KF, van Gulik TM, et al. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology. 2010;256(1):159–68.CrossRefPubMed van Werven JR, Marsman HA, Nederveen AJ, Smits NJ, Ten KF, van Gulik TM, et al. Assessment of hepatic steatosis in patients undergoing liver resection: comparison of US, CT, T1-weighted dual-echo MR imaging, and point-resolved 1H MR spectroscopy. Radiology. 2010;256(1):159–68.CrossRefPubMed
10.
go back to reference Shi KQ, Tang JZ, Zhu XL, Ying L, Li DW, Gao J, et al. Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: a meta-analysis of diagnostic accuracy. J Gastroenterol Hepatol. 2014;29(6):1149–58.CrossRefPubMed Shi KQ, Tang JZ, Zhu XL, Ying L, Li DW, Gao J, et al. Controlled attenuation parameter for the detection of steatosis severity in chronic liver disease: a meta-analysis of diagnostic accuracy. J Gastroenterol Hepatol. 2014;29(6):1149–58.CrossRefPubMed
11.
go back to reference Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. Clin Res Hepatol Gastroenterol. 2012;36(1):13–20.CrossRefPubMed Sasso M, Miette V, Sandrin L, Beaugrand M. The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan. Clin Res Hepatol Gastroenterol. 2012;36(1):13–20.CrossRefPubMed
12.
go back to reference Gatos I, Drazinos P, Yarmenitis S, Theotokas I, Koskinas J, Koullias E, et al. Liver ultrasound attenuation: an ultrasound attenuation index for liver steatosis assessment. Ultrasound Q. 2022;38(2):124–32.CrossRefPubMed Gatos I, Drazinos P, Yarmenitis S, Theotokas I, Koskinas J, Koullias E, et al. Liver ultrasound attenuation: an ultrasound attenuation index for liver steatosis assessment. Ultrasound Q. 2022;38(2):124–32.CrossRefPubMed
13.
go back to reference Dioguardi BM, Imbault M, Ronot M, Faccinetto A, Van Beers BE, Rautou PE, et al. Ultrasonic adaptive sound speed estimation for the diagnosis and quantification of hepatic steatosis: a pilot study. Ultraschall Med. 2019;40(6):722–33.CrossRef Dioguardi BM, Imbault M, Ronot M, Faccinetto A, Van Beers BE, Rautou PE, et al. Ultrasonic adaptive sound speed estimation for the diagnosis and quantification of hepatic steatosis: a pilot study. Ultraschall Med. 2019;40(6):722–33.CrossRef
14.
go back to reference Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol. 2011;21(1):87–97.CrossRefPubMed Bohte AE, van Werven JR, Bipat S, Stoker J. The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis. Eur Radiol. 2011;21(1):87–97.CrossRefPubMed
15.
go back to reference Wong VW, Chu WC, Wong GL, Chan RS, Chim AM, Ong A, et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut. 2012;61(3):409–15.CrossRefPubMed Wong VW, Chu WC, Wong GL, Chan RS, Chim AM, Ong A, et al. Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography. Gut. 2012;61(3):409–15.CrossRefPubMed
16.
go back to reference Ferraioli G, Wong VW, Castera L, Berzigotti A, Sporea I, Dietrich CF, et al. Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations. Ultrasound Med Biol. 2018;44(12):2419–40.CrossRefPubMed Ferraioli G, Wong VW, Castera L, Berzigotti A, Sporea I, Dietrich CF, et al. Liver ultrasound elastography: an update to the world federation for ultrasound in medicine and biology guidelines and recommendations. Ultrasound Med Biol. 2018;44(12):2419–40.CrossRefPubMed
17.
go back to reference Petta S, Maida M, Macaluso FS, Di Marco V, Camma C, Cabibi D, et al. The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease. Hepatology. 2015;62(4):1101–10.CrossRefPubMed Petta S, Maida M, Macaluso FS, Di Marco V, Camma C, Cabibi D, et al. The severity of steatosis influences liver stiffness measurement in patients with nonalcoholic fatty liver disease. Hepatology. 2015;62(4):1101–10.CrossRefPubMed
18.
go back to reference Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol. 2011;54(1):64–71.CrossRefPubMed Gaia S, Carenzi S, Barilli AL, Bugianesi E, Smedile A, Brunello F, et al. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis. J Hepatol. 2011;54(1):64–71.CrossRefPubMed
19.
go back to reference EASL-ALEH Clinical Practice Guidelines. Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237–64.CrossRef EASL-ALEH Clinical Practice Guidelines. Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63(1):237–64.CrossRef
20.
go back to reference Herrmann E, de Ledinghen V, Cassinotto C, Chu WC, Leung VY, Ferraioli G, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis. Hepatology. 2018;67(1):260–72.CrossRefPubMed Herrmann E, de Ledinghen V, Cassinotto C, Chu WC, Leung VY, Ferraioli G, et al. Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: an individual patient data-based meta-analysis. Hepatology. 2018;67(1):260–72.CrossRefPubMed
21.
go back to reference Dietrich CF, Bamber J, Berzigotti A, Bota S, Cantisani V, Castera L, et al. EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version). Ultraschall Med. 2017;38(4):e16-47.CrossRefPubMed Dietrich CF, Bamber J, Berzigotti A, Bota S, Cantisani V, Castera L, et al. EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, update 2017 (long version). Ultraschall Med. 2017;38(4):e16-47.CrossRefPubMed
22.
go back to reference Yang J, Lin L, Xue E, Hong D, Yang Y, Xu M, et al. Can nonfibrotic nonalcoholic steatohepatitis be effectively identified by supersonic shear imaging? Anal Cell Pathol (Amst). 2019;2019:2013674.PubMed Yang J, Lin L, Xue E, Hong D, Yang Y, Xu M, et al. Can nonfibrotic nonalcoholic steatohepatitis be effectively identified by supersonic shear imaging? Anal Cell Pathol (Amst). 2019;2019:2013674.PubMed
23.
go back to reference Garcovich M, Veraldi S, Di Stasio E, Zocco MA, Monti L, Toma P, et al. Liver stiffness in pediatric patients with fatty liver disease: diagnostic accuracy and reproducibility of shear-wave elastography. Radiology. 2017;283(3):820–7.CrossRefPubMed Garcovich M, Veraldi S, Di Stasio E, Zocco MA, Monti L, Toma P, et al. Liver stiffness in pediatric patients with fatty liver disease: diagnostic accuracy and reproducibility of shear-wave elastography. Radiology. 2017;283(3):820–7.CrossRefPubMed
24.
go back to reference Huang Z, Zhou J, Lu X, Zhang T, Xu S, Jin J, et al. How does liver steatosis affect diagnostic performance of 2D-SWE.SSI: assessment from aspects of steatosis degree and pathological types. Eur radiol. 2021;31(5):3207–15.CrossRefPubMed Huang Z, Zhou J, Lu X, Zhang T, Xu S, Jin J, et al. How does liver steatosis affect diagnostic performance of 2D-SWE.SSI: assessment from aspects of steatosis degree and pathological types. Eur radiol. 2021;31(5):3207–15.CrossRefPubMed
25.
go back to reference Martins PN, Neuhaus P. Surgical anatomy of the liver, hepatic vasculature and bile ducts in the rat. Liver Int. 2007;27(3):384–92.CrossRefPubMed Martins PN, Neuhaus P. Surgical anatomy of the liver, hepatic vasculature and bile ducts in the rat. Liver Int. 2007;27(3):384–92.CrossRefPubMed
26.
go back to reference Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–21.CrossRefPubMed Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41(6):1313–21.CrossRefPubMed
27.
go back to reference Lau JK, Zhang X, Yu J. Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances. J Pathol. 2017;241(1):36–44.CrossRefPubMed Lau JK, Zhang X, Yu J. Animal models of non-alcoholic fatty liver disease: current perspectives and recent advances. J Pathol. 2017;241(1):36–44.CrossRefPubMed
29.
go back to reference Ogawa S, Moriyasu F, Yoshida K, Oshiro H, Kojima M, Sano T, et al. Relationship between liver tissue stiffness and histopathological findings analyzed by shear wave elastography and compression testing in rats with non-alcoholic steatohepatitis. J Med Ultrason (2001). 2016;43(3):355–60.CrossRefPubMed Ogawa S, Moriyasu F, Yoshida K, Oshiro H, Kojima M, Sano T, et al. Relationship between liver tissue stiffness and histopathological findings analyzed by shear wave elastography and compression testing in rats with non-alcoholic steatohepatitis. J Med Ultrason (2001). 2016;43(3):355–60.CrossRefPubMed
30.
go back to reference Nightingale KR, Rouze NC, Rosenzweig SJ, Wang MH, Abdelmalek MF, Guy CD, et al. Derivation and analysis of viscoelastic properties in human liver: impact of frequency on fibrosis and steatosis staging. IEEE Trans Ultrason Ferroelectr Freq Control. 2015;62(1):165–75.CrossRefPubMedPubMedCentral Nightingale KR, Rouze NC, Rosenzweig SJ, Wang MH, Abdelmalek MF, Guy CD, et al. Derivation and analysis of viscoelastic properties in human liver: impact of frequency on fibrosis and steatosis staging. IEEE Trans Ultrason Ferroelectr Freq Control. 2015;62(1):165–75.CrossRefPubMedPubMedCentral
31.
go back to reference Mendoza YP, Rodrigues SG, Delgado MG, Murgia G, Lange NF, Schropp J, et al. Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two-dimensional shear wave elastography in non-alcoholic fatty liver disease. Liver Int. 2021;42(1):102–11.CrossRefPubMedPubMedCentral Mendoza YP, Rodrigues SG, Delgado MG, Murgia G, Lange NF, Schropp J, et al. Inflammatory activity affects the accuracy of liver stiffness measurement by transient elastography but not by two-dimensional shear wave elastography in non-alcoholic fatty liver disease. Liver Int. 2021;42(1):102–11.CrossRefPubMedPubMedCentral
32.
go back to reference Cassinotto C, Boursier J, de Ledinghen V, Lebigot J, Lapuyade B, Cales P, et al. Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology. 2016;63(6):1817–27.CrossRefPubMed Cassinotto C, Boursier J, de Ledinghen V, Lebigot J, Lapuyade B, Cales P, et al. Liver stiffness in nonalcoholic fatty liver disease: a comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy. Hepatology. 2016;63(6):1817–27.CrossRefPubMed
33.
go back to reference Vetelainen R, van Vliet A, van Gulik TM. Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model. J Gastroenterol Hepatol. 2007;22(9):1526–33.CrossRefPubMed Vetelainen R, van Vliet A, van Gulik TM. Essential pathogenic and metabolic differences in steatosis induced by choline or methione-choline deficient diets in a rat model. J Gastroenterol Hepatol. 2007;22(9):1526–33.CrossRefPubMed
34.
go back to reference Tandra S, Yeh MM, Brunt EM, Vuppalanchi R, Cummings OW, Unalp-Arida A, et al. Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. J Hepatol. 2011;55(3):654–9.CrossRefPubMed Tandra S, Yeh MM, Brunt EM, Vuppalanchi R, Cummings OW, Unalp-Arida A, et al. Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease. J Hepatol. 2011;55(3):654–9.CrossRefPubMed
35.
go back to reference Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis. 2007;11(1):1–16.CrossRefPubMed Ong JP, Younossi ZM. Epidemiology and natural history of NAFLD and NASH. Clin Liver Dis. 2007;11(1):1–16.CrossRefPubMed
36.
go back to reference Lee MS, Bae JM, Joo SK, Woo H, Lee DH, Jung YJ, et al. Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease. PLoS ONE. 2017;12(11): e188321.CrossRef Lee MS, Bae JM, Joo SK, Woo H, Lee DH, Jung YJ, et al. Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease. PLoS ONE. 2017;12(11): e188321.CrossRef
37.
go back to reference Kang BK, Lee SS, Cheong H, Hong SM, Jang K, Lee MG. Shear wave elastography for assessment of steatohepatitis and hepatic fibrosis in rat models of non-alcoholic fatty liver disease. Ultrasound Med Biol. 2015;41(12):3205–15.CrossRefPubMed Kang BK, Lee SS, Cheong H, Hong SM, Jang K, Lee MG. Shear wave elastography for assessment of steatohepatitis and hepatic fibrosis in rat models of non-alcoholic fatty liver disease. Ultrasound Med Biol. 2015;41(12):3205–15.CrossRefPubMed
38.
go back to reference Sugimoto K, Moriyasu F, Oshiro H, Takeuchi H, Yoshimasu Y, Kasai Y, et al. Viscoelasticity measurement in rat livers using shear-wave US elastography. Ultrasound Med Biol. 2018;44(9):2018–24.CrossRefPubMed Sugimoto K, Moriyasu F, Oshiro H, Takeuchi H, Yoshimasu Y, Kasai Y, et al. Viscoelasticity measurement in rat livers using shear-wave US elastography. Ultrasound Med Biol. 2018;44(9):2018–24.CrossRefPubMed
39.
go back to reference Takeuchi H, Sugimoto K, Oshiro H, Iwatsuka K, Kono S, Yoshimasu Y, et al. Liver fibrosis: noninvasive assessment using supersonic shear imaging and FIB4 index in patients with non-alcoholic fatty liver disease. J Med Ultrason (2001). 2018;45(2):243–9.CrossRefPubMed Takeuchi H, Sugimoto K, Oshiro H, Iwatsuka K, Kono S, Yoshimasu Y, et al. Liver fibrosis: noninvasive assessment using supersonic shear imaging and FIB4 index in patients with non-alcoholic fatty liver disease. J Med Ultrason (2001). 2018;45(2):243–9.CrossRefPubMed
40.
go back to reference Yoshioka Y, Hashimoto E, Yatsuji S, Kaneda H, Taniai M, Tokushige K, et al. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out Nash. J Gastroenterol. 2004;39(12):1215–8.CrossRefPubMed Yoshioka Y, Hashimoto E, Yatsuji S, Kaneda H, Taniai M, Tokushige K, et al. Nonalcoholic steatohepatitis: cirrhosis, hepatocellular carcinoma, and burnt-out Nash. J Gastroenterol. 2004;39(12):1215–8.CrossRefPubMed
Metadata
Title
Diagnostic efficiency on ultrasound shear wave elastography in evaluation of steatosis severity for non-alcoholic fatty liver disease: a rat model
Authors
Yuhui Wu
Qianjiao Liu
Yan Wang
Fangyan Li
Lawrence Wing-Chi Chan
Yong Wen
Fan Yang
Yining Xiang
Qinghong Duan
Peng Luo
Pinggui Lei
Publication date
01-12-2023
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2023
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-023-01042-5

Other articles of this Issue 1/2023

European Journal of Medical Research 1/2023 Go to the issue